Artificial intelligence (AI) software developer Mindshare Medical has received the CE Mark for the sale of its RevealAI-Lung, AI-based software designed to detect lung cancer on CT scans.
RevealAI-Lung is a computer-assisted diagnostic software designed to improve the accuracy and efficiency of detecting lung cancer as well as optimize recommendations for future patient care, Mindshare said. The software may also help support CT lung cancer screening programs throughout Europe.
